Assembly Biosciences (ASMB) Leases (2019 - 2025)
Assembly Biosciences (ASMB) has 7 years of Leases data on record, last reported at $2.6 million in Q3 2025.
- For Q3 2025, Leases rose 86.07% year-over-year to $2.6 million; the TTM value through Sep 2025 reached $2.6 million, up 86.07%, while the annual FY2024 figure was $3.1 million, 31.21% up from the prior year.
- Leases reached $2.6 million in Q3 2025 per ASMB's latest filing, down from $2.8 million in the prior quarter.
- Across five years, Leases topped out at $8.1 million in Q1 2021 and bottomed at $844000.0 in Q3 2023.
- Average Leases over 5 years is $3.7 million, with a median of $2.9 million recorded in 2025.
- Peak YoY movement for Leases: crashed 78.68% in 2023, then soared 86.07% in 2025.
- A 5-year view of Leases shows it stood at $6.0 million in 2021, then plummeted by 47.12% to $3.2 million in 2022, then dropped by 26.79% to $2.3 million in 2023, then skyrocketed by 31.21% to $3.1 million in 2024, then fell by 13.85% to $2.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $2.6 million in Q3 2025, $2.8 million in Q2 2025, and $2.9 million in Q1 2025.